Published in Nature on January 31, 2013
Novo awaits green light for diabetes drug. Nat Biotechnol (2009) 1.39
A better lens on disease. Sci Am (2010) 1.37
Mutations to the rescue. Nat Med (2011) 0.91
From cells, secrets of the secretome leak out. Nat Med (2009) 0.89
Drug development: Time for teamwork. Nature (2014) 0.88
Aiding adherence: five approaches to following prescriptions. Nat Med (2010) 0.83
Statistics: Attacking an epidemic. Nature (2014) 0.82
Engineering a new business. Nat Biotechnol (2009) 0.80
The spine. Nature (2013) 0.78
Biomarkers still off the mark for detecting breast cancer. Nat Med (2010) 0.77
Hind-limb paraparesis in a rat model for neurolathyrism associated with apoptosis and an impaired vascular endothelial growth factor system in the spinal cord. J Comp Neurol (2010) 0.77
Focus on electronic health records. 'HIPAA2' legislation means more delicate handling of data. Nat Med (2010) 0.77
Drug companies hope to breathe life into asthma pipeline. Nat Med (2011) 0.76
Forecast calls for clouds over biological computing. Nat Med (2010) 0.75
Regenerative medicine: Rebuilding the backbone. Nature (2013) 0.75
Sex on the brain: Unraveling the differences between women and men in neurodegenerative disease. Nat Med (2016) 0.75
Stanford program gives discoveries a shot at commercialization. Nat Med (2011) 0.75
Destroying newborn blood samples threatens birth defect research. Nat Med (2010) 0.75
Focus on electronic health records. Grassley probes health care technology. Nat Med (2010) 0.75
Brazilian drug companies hope to benefit from foreign investment. Nat Med (2011) 0.75
Harvard Medical School rescinds controversial media rules. Nat Med (2009) 0.75
Attacking an epidemic. Sci Am (2014) 0.75
'Machine or transformation test' put to the test itself. Nat Med (2009) 0.75
Scientific American 50. Sci Am (2002) 0.75
Stem cells serve as new platform for biodefense preparedness. Nat Med (2010) 0.75
Lab studies and early clinical trials suggest that RNAi could become a potent new approach to treating many medical conditions, including autoimmune diseases, cancer, influenza, and more. Biotechniques (2007) 0.75
Nature Index 2015 Global. Nature (2015) 0.75
Family data underused to track disease. Nat Med (2010) 0.75
Antibiotics. Nature (2014) 0.75
FDA reorganization inspires hope for better coordination. Nat Med (2011) 0.75
Adding sugar to bioscience. A tennis game leads to a method for sequencing polysaccharides. Sci Am (2002) 0.75
Epilepsy. Nature (2014) 0.75
Nature index 2015 Asia-Pacific. Nature (2015) 0.75